PubRank

Stefania Croci

Author PubWeight™ 19.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Cancer Res 2005 2.09
2 Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. Cancer Res 2004 1.25
3 In silico modeling and in vivo efficacy of cancer-preventive vaccinations. Cancer Res 2010 1.17
4 Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. Proc Natl Acad Sci U S A 2009 1.14
5 Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Cancer Res 2003 1.08
6 Antimetastatic activity of a preventive cancer vaccine. Cancer Res 2007 1.07
7 Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. J Immunol 2004 1.04
8 High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy. Eur J Cancer 2009 1.00
9 Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor. PLoS One 2012 0.99
10 Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. Am J Pathol 2005 0.97
11 Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. PLoS Pathog 2013 0.89
12 Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2. Breast Cancer Res 2014 0.89
13 Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12. Int J Cancer 2003 0.88
14 Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. Mol Cancer Ther 2009 0.83
15 Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. Oncotarget 2014 0.81
16 Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. Int J Cancer 2004 0.81
17 HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines. Vaccine 2011 0.80
18 Synthesis and characterization of (68)Ga-labeled curcumin and curcuminoid complexes as potential radiotracers for imaging of cancer and Alzheimer's disease. Inorg Chem 2014 0.77
19 Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role. Eur J Cancer 2006 0.75
20 Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. Int J Cancer 2007 0.75
21 Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. Vaccine 2009 0.75